SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description

   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Clinical Updates for Nurse Practitioners and Physician Assistants: 2017 Philadelphia, PA
Activity/Course #:
: 10.14.17CU

Cost:
: Free
Release/Start Date:
: Oct 14 2017
Expiration Date:
: Oct 14 2017
Topics:
: Primary Care Medicine
Target Audience:
: Nurse Practitioners and Physician Assistants
Format:
: Live NP PA Conference
Estimated Time To Complete CME Activity:
: 7.0 hours
Credit(s):
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 3.0 pharmacology hour(s)
Hardware/Software Requirements:

Saturday, October 14, 2017

Sheraton Valley Forge
480 N. Gulph Rd.
King of Prussia, PA 19406
(484) 238-1800

Registration Fee

There is no registration fee for this activity.

Special Accommodations

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking

Complimentary self-parking is available at the hotel.

Hotel Guest Rooms

NACE has reserved a sleeping room rate of $129 per night at the Sheraton Valley Forge Hotel. To reserve your room at this rate, call reservations at (484) 238-1800 and ask for the NACE room block by September 13, 2017.

Program Summary

Nurse practitioners and physician assistants as primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives
At the conclusion of this program, participants should be able to:
  1. Describe the role of insulin therapy in patients with T2DM not meeting glycemic goals; Discuss the need for concentrated insulins in T2DM management; Discuss the pharmacokinetic/pharmacodynamic profiles and other considerations for the use of concentrated insulin preparations; Recognize the need for counseling patients about concentrated insulins to minimize dosing errors.
  2. Review current recommendations for the use of non-statin therapies in the management of dyslipidemia; Explain the role of anti-PCSK9 monoclonal antibody therapy in LDL-C reduction to achieve cardiovascular risk reduction; Describe the findings from recent trials of dyslipidemia treatments on cardiovascular outcomes; Integrate new data into treatment strategies for further improving cardiovascular outcomes in the highest risk patients.
  3. Recognize the different phenotypic presentations of HF; Identify predictors of poor outcomes in HF; Discuss the role of new therapies in the management of chronic HF according to the latest ACC/AHA/HFSA/ADA guidelines; Recognize strategies to reduce hospitalization for HF.
  4. Recognize the pervasive nature of ADHD symptoms throughout the day; Describe the physical and psychologic morbidity and mortality associated with ADHD; Use adult ADHD assessment and treatment tools to measure residual symptoms and optimize outcomes; Implement pharmacologic treatment to optimize symptom control throughout the day.
  5. Identify USPSTF-defined HBV endemic areas to more effectively identify first- and second-generation immigrant populations that should be screened for HBV; Develop effective plans to overcome culture-specific barriers to screening your patient populations; Evaluate patient cases to identify when to screen patients and how to refer to specialist care for treatment; Describe current treatment guidelines and newly available HBV therapies; Discuss the importance of early screening and treatment in specific patient populations, including pregnant and postpartum women.
  6. Discuss the pathophysiology of pulmonary arterial hypertension (PAH); Recognize signs and symptoms suggestive of PAH and the appropriate diagnostic strategy; Describe how to monitor patients with PAH for disease progression; Review current and emerging treatments for patients with PAH.

Agenda

7:30-8:00

  Continental Breakfast and Registration
8:00-8:10   Welcome Remarks
Deborah Paschal, CRNP
8:10-9:20  

Utilizing Concentrated Insulins: A New Strategy for the Insulin Resistant
Mark Stolar, MD

9:20-10:30  

Putting Emerging Lipids Data Into Practice: New Treatments and Opportunities to Reduce Cardiovascular Risk
Anekwe Onwuanyi, MD, FACC, FAHA, FACP, FHFSA

10:30-10:50   Break
10:50-12:00  

Recognizing Phenotypes and Evidence Based Treatments in the Management of Heart Failure
Anekwe Onwuanyi, MD, FACC, FAHA, FACP, FHFSA

12:00-1:10  

Lunch
Presentation Theater: A Patient-Centered Approach to Help Awaken a Transformation for Adults With T2DM

Michael Attanasio, DO
(CME not offered)

1:10-2:20   Making a Difference in ADHD: Screening and Treating for Primary Care
Brendan Montano, MD
2:20-3:30   Screening, Counseling, and Linkage to Care Education in Hepatitis B
Ponni V. Perumalswami, MD, MCR
 3:30-3:45  

Break

 3:45-4:55  

Clinical Advances in Pulmonary Arterial Hypertension
Melisa Wilson, ARNP

4:55-5:00   Program Summary and Closing Remarks
Deborah Paschal, CRNP


*Agenda subject to change.

Faculty

Brendan Montano, MD
Private Practice, Internal Medicine          
Assistant Clinical Instructor
University of Connecticut Health Center
Director, Connecticut Clinical Research
Farmington, CT

Anekwe Onwuanyi, MD, FACC, FAHA, FACP, FHFSA
Professor of Medicine
Chief of Cardiology
Morehouse School of Medicine
Medical Director, Heart Failure Program
Grady Health System
Atlanta, GA

Ponni V. Perumalswami, MD, MCR
Assistant Professor of Medicine
Division of Liver Diseases/RMTI
Department of Medicine
Director of Hepatitis Outreach Network
Icahn School of Medicine at Mount Sinai
New York, NY

Mark Stolar, MD
Associate Professor of Clinical Medicine
Feinberg School of Medicine
Northwestern University
Chicago, IL

Melisa Wilson, ARNP
Pulmonary Hypertension Nurse Practitioner and Coordinator
Center for Pulmonary Hypertension and CVD at Florida Hospital
Orlando, FL

Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Deborah Paschal, CRNP
Course Director
Clinical Nurse Practitioner
Philadelphia, PA

Daniela Hiedra
Activity Director
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education

Plantation, FL

Cassandra A. McCullough, MBA

Chief Executive Officer

Association of Black Cardiologists

New York, NY

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education

Plantation, FL

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7 contact hours of continuing education (which includes 3.0 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
Clinical Updates for Nurse Practitioners and Physician Assistants: 2017 is supported by an educational grant from Actelion Pharmaceuticals US, Inc; educational funding provided by Amgen; an educational grant from Gilead Sciences, Inc.; an educational grant from Novartis Pharmaceuticals Corporation; an educational grant from Sanofi US; and an independent medical educational grant from Shire.